<https://rdf.molmedb.upol.cz/reference/ref1241> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17285>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2009.08.066"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target69>;
	<http://purl.org/ontology/bibo/pmid> "19740658"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M.: Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2. Bioorg Med Chem Lett, Volume 19 (20), 2009"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource> .
<https://rdf.molmedb.upol.cz/transporter/tra58989> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1241> .